Product Description

🔹 Product Overview
Etibo 250 mg Tablet is a prescription anticancer medicine used in the treatment of certain types of breast cancer.
Contains Lapatinib 250 mg, a targeted therapy that helps slow or stop the growth of cancer cells.
Commonly prescribed for HER2-positive advanced or metastatic breast cancer as part of a comprehensive cancer treatment plan.

🔹 Key Uses
Treatment of HER2-positive breast cancer
Management of advanced breast cancer
Used in combination with other anticancer medicines when recommended by an oncologist
Helps slow the growth and spread of cancer cells

🔹 Composition
Active ingredient: Lapatinib 250 mg
Belongs to the tyrosine kinase inhibitor (TKI) class of medicines
Used in targeted cancer therapy

🔹 How It Works
Blocks specific proteins (HER2 and EGFR receptors) involved in cancer cell growth
Helps prevent multiplication of cancer cells
Slows disease progression and supports cancer management

🔹 Key Benefits
Effective targeted therapy for HER2-positive breast cancer
Helps control cancer progression
Can be used as part of combination cancer treatment
Supports improved treatment outcomes under specialist supervision

🔹 Dosage and Administration
Take exactly as prescribed by an oncologist
Usually taken on an empty stomach
Swallow tablets whole with water
Follow the prescribed treatment schedule carefully

🔹 Possible Side Effects
Diarrhea
Nausea
Fatigue
Headache
Rash
Abdominal discomfort

🔹 Precautions
Use only under specialist medical supervision
Regular monitoring of liver function and heart health may be required
Inform your doctor about all medicines you are taking
Avoid use during pregnancy unless specifically advised
Attend all scheduled follow-up appointments during treatment